Kymera Therapeutics Inc.

NASDAQ: KYMR · Real-Time Price · USD
42.62
1.07 (2.58%)
At close: Aug 15, 2025, 3:59 PM
43.44
1.92%
After-hours: Aug 15, 2025, 05:03 PM EDT

Kymera Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-76.61M -65.58M -70.75M -62.49M -42.06M -48.56M -14.37M -52.87M -38.8M -40.93M -34.87M -43M -40.26M -36.68M -33.9M -28.58M -24.66M -13.07M
Depreciation & Amortization
2.08M 2.05M 2.02M 1.99M 1.9M 1.46M 891K 895K 900K 879K 818K 767K 705K 687K 689K 671K 552K 485K
Stock-Based Compensation
15.42M 14.23M 13.8M 14.9M 14.34M 11.97M 10.9M 11.65M 11.18M 9.38M 8.91M 9.08M 9.62M 7.87M 8.68M 7.4M 5.73M 3.17M
Other Working Capital
25.48M -12.19M -3.42M -1.45M -13.49M -7.98M 10.36M 8.87M -4.39M -14.2M -11.43M -6.84M -9.32M -11.91M -16.61M -15.5M -13.22M -18.83M
Other Non-Cash Items
-2.12M -2.52M -3.31M -3.62M 13.8M 15.28M -1.27M -10.37M -10.09M -1.33M -905K -2.56M 677K 1.18M 1.64M 1.68M 1.23M 1.28M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -17.82M 9.15M 8.67M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
1.35M -27.32M -3.55M -971K -13.13M -6.32M 11.89M 9.89M -7.12M -11.98M -13.49M -1.05M -9.73M -13.35M -15.46M -18.42M -13.36M -14.68M
Operating Cash Flow
-59.88M -79.15M -61.78M -50.19M -42.94M -39.59M 8.04M -31.65M -35.26M -43.97M -39.54M -34.27M -38.98M -40.3M -38.35M -37.26M -30.51M -22.82M
Capital Expenditures
-695K -467K -936K 189K -4.69M -7.4M -11.63M -8.08M -10.77M -4.01M -373K -1.25M -735K -482K -501K -306K -626K -164K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -30.58M -68.59M -46.61M -1.33M 889K n/a -82.54M 1.18M 5.81M n/a n/a 1.28M
Purchase of Investments
-58.25M -83.66M -78.42M -295.94M -104.16M -422.7M -45.5M -29.17M -52.64M -61.84M -147.24M -153.91M -64.71M -80.12M -164.4M -245.84M -30.15M -16.01M
Sales Maturities Of Investments
116.85M 130.21M 147.93M 127.36M 124.49M 99.5M 76.08M 97.76M 99.25M 90.43M 97.94M 117.67M 147.25M 106.46M 96.88M 109.29M 91.5M 60.5M
Other Investing Acitivies
2.12M 2.52M n/a 10.72M 20.33M 3.07M 30.58M 68.59M 46.61M 1.33M -889K -36.23M 82.54M -1.18M -5.81M n/a n/a -1.28M
Investing Cash Flow
60.02M 48.62M 68.57M -157.68M 15.64M -330.61M 18.95M 60.51M 35.84M 24.58M -49.67M -37.48M 81.8M 25.86M -68.02M -136.86M 60.72M 44.32M
Debt Repayment
-382K -277K -293K -641K -352K -290K 925K -340K -334K -327K -305K -292K -269K -264K -156K -352K -186K -155K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 599.68M 5.05M 1.76M 3.93M 1.01M n/a 1.64M 1.49M 2.26M 150.79M 633K 449K 2.24M 246.39M 1.78M 750K
Financial Cash Flow
245.73M 258K 2.77M 250.92M 1.41M 353.76M 1.93M -206K 1.3M 1.16M 1.95M 150.5M 364K 185K 2.05M 246.04M 1.59M 595K
Net Cash Flow
245.86M -30.28M 9.55M 43.05M -25.9M -16.46M 28.93M 28.66M 1.89M -18.23M -87.25M 78.75M 43.18M -14.25M -104.32M 71.92M 31.8M 22.09M
Free Cash Flow
-60.58M -79.62M -62.72M -50M -47.63M -46.99M -3.58M -39.73M -46.02M -47.98M -39.91M -35.52M -39.72M -40.78M -38.85M -37.57M -31.14M -22.99M